Coronavirus

J&J Vaccine Could Be a ‘Game Changer.' Here's Why a Third Option Matters

Experts say the newly authorized vaccine could play a key role in staving off another surge of infections

NBCUniversal Media, LLC Johnson & Johnson’s COVID-19 vaccine began shipping out on Monday morning after the Food and Drug Administration granted emergency use authorization on Saturday.

Having two vaccines is good. But three is better — and it could make a major difference in getting the pandemic under control, NBC News reports.

"It could be a total game changer," said Dr. Muriel Jean-Jacques, an assistant professor of medicine at Northwestern University.

Millions of doses of the COVID-19 vaccine developed by Johnson & Johnson will soon be available in the U.S., a much-anticipated development that could help turn the tide of the pandemic by vastly speeding the rate at which people are vaccinated.

Experts say the newly authorized vaccine could play a key role in staving off another surge of infections, particularly as the recent sharp declines in reported cases of COVID-19 appear to be leveling off and rising once again.

Read the full story at NBCNews.com.

Exit mobile version